Dathan Hamann is a Dermatology physician affiliated with HonorHealth. OpenAlex indexes 74 publications with 1,232 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 E Mcdowell Rd
Phoenix, AZ 850083884
Telephone
480-681-3300Provider last certified this registry record 22 Mar 2021.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year202520 payments$25,014openpaymentsdata.cms.gov ↗
- Incyte CorporationProgram year20257 payments
- Galderma Laboratories, L.P.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
40.8%Corticosteroid34.9%Triamcinolone Acetonide86%Fluocinolone Acetonide15%Part D≥71 patientsPolyene Antifungal3%Nystatin100%Part D<11 patients+ 1 more class in this area
Sensory organs
16.7%Corticosteroid16.7%Clobetasol Propionate77%Betamethasone Dipropionate23%Part D≥37 patientsAnti-infectives
14.2%Azole Antifungal11.1%Ketoconazole100%Part D≥21 patientsTetracycline-class Drug3%Doxycycline Hyclate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Two cases of drug-induced psoriasis from second-generation androgen receptor blockers
Clinical and Experimental Dermatology
2024 - Value Proposition of Epicutaneous Patch Testing: A Win-Win for the Patient and the Medical System
Current Dermatology Reports
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Tania Phillips, MD
HonorHealth
Erkut Borazanci, MD, MS
HonorHealth
Zain Khalpey, MD, MRCS
HonorHealth
Venkatesh Ramaiah, MD
HonorHealth
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”